Doximity, Inc. (DOCS) stock
Close on Nov 11, 2026Market cap $5.92BP/E 46.1Yield –
Earnings
Doximity's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Doximity's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2027ended Dec 31, 2026 | Feb 4, 2027Expected | – | – | – | – | – |
| Q2 FY2027ended Sep 30, 2026 | Nov 5, 2026after the close | $174.50M | +3.6% | $0.18 | $0.36 | Release |
| Q1 FY2027ended Jun 30, 2026 | Aug 6, 2026after the close | $156.60M | +7.3% | $0.13 | $0.29 | Release |
| Q4 FY2026ended Mar 31, 2026 | May 13, 2026after the close | $145.40M | +5.1% | $0.10 | $0.26 | Release |
| Q3 FY2026ended Dec 31, 2025 | Feb 5, 2026after the close | $185.10M | +9.8% | $0.31 | $0.46 | Release |
| Q2 FY2026ended Sep 30, 2025 | Nov 6, 2025after the close | $168.50M | +23.2% | $0.31 | $0.45 | Release |
| Q1 FY2026ended Jun 30, 2025 | Aug 7, 2025after the close | $145.90M | +15.2% | $0.27 | $0.36 | Release |
| Q4 FY2025ended Mar 31, 2025 | May 15, 2025after the close | $138.30M | +17.1% | $0.31 | $0.38 | Release |
| Q3 FY2025ended Dec 31, 2024 | Feb 6, 2025after the close | $168.60M | +24.6% | $0.37 | $0.45 | Release |
| Q2 FY2025ended Sep 30, 2024 | Nov 7, 2024after the close | $136.80M | +20.4% | $0.22 | $0.30 | Release |
| Q1 FY2025ended Jun 30, 2024 | Aug 8, 2024after the close | $126.70M | +16.8% | $0.21 | $0.28 | Release |
| Q4 FY2024ended Mar 31, 2024 | May 16, 2024after the close | $118.10M | +6.4% | $0.20 | $0.25 | Release |
| Q3 FY2024ended Dec 31, 2023 | Feb 8, 2024after the close | $135.30M | +17.3% | $0.24 | $0.29 | Release |
| Q2 FY2024ended Sep 30, 2023 | Nov 9, 2023after the close | $113.60M | +11.2% | $0.15 | $0.22 | Release |
| Q1 FY2024ended Jun 30, 2023 | Aug 8, 2023after the close | $108.50M | +19.8% | $0.13 | $0.19 | Release |
| Q4 FY2023ended Mar 31, 2023 | May 16, 2023after the close | $111.00M | +18.5% | $0.14 | $0.20 | Release |
| Q3 FY2023ended Dec 31, 2022 | Feb 9, 2023after the close | $115.30M | +17.8% | $0.16 | $0.22 | Release |
| Q2 FY2023ended Sep 30, 2022 | Nov 10, 2022after the close | $102.20M | +28.7% | $0.12 | $0.17 | Release |
| Q1 FY2023ended Jun 30, 2022 | Aug 4, 2022after the close | $90.60M | – | $0.10 | $0.14 | Release |
| Q4 FY2022ended Mar 31, 2022 | May 17, 2022after the close | $93.70M | – | $0.17 | $0.21 | Release |
| Q3 FY2022ended Dec 31, 2021 | Feb 8, 2022after the close | $97.90M | – | $0.26 | $0.29 | Release |
| Q2 FY2022ended Sep 30, 2021 | Nov 9, 2021after the close | $79.40M | – | $0.17 | $0.19 | Release |
| Q1 FY2022ended Jun 30, 2021 | Aug 10, 2021after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Doximity's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenueGAAP | Q3 FY2027 | $195.00M – $196.00M | – | – | Nov 5, 2026 |
| Adjusted EBITDAnon-GAAP | Q3 FY2027 | $102.50M – $103.50M | – | – | Nov 5, 2026 |
| RevenueGAAP | FY2027 | $678.00M – $683.00M | – | – | Nov 5, 2026 |
| Revenue | FY2027 | $671.00M – $681.00M | $664.00M – $676.00M | Raised | Aug 6, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $317.00M – $325.00M | – | – | Nov 5, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $309.00M – $329.00M | $323.00M – $335.00M | Lowered | Aug 6, 2026 |
Guidance vs results
The last range Doximity gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2027 | Revenue | $170.00M – $171.00M | $174.50M | Above range |
| Q1 FY2027 | Revenue | $151.00M – $152.00M | $156.60M | Above range |
| FY2026 | Revenue | $642.50M – $643.50M | $644.90MΣ4Q | Above range |
| Q4 FY2026 | Revenue | $143.00M – $144.00M | $145.40M | Above range |
| Q3 FY2026 | Revenue | $180.00M – $181.00M | $185.10M | Above range |
| Q2 FY2026 | Revenue | $157.00M – $158.00M | $168.50M | Above range |
| Q1 FY2026 | Revenue | $139.00M – $140.00M | $145.90M | Above range |
| FY2025 | Revenue | $564.60M – $565.60M | $570.40MΣ4Q | Above range |
| Q4 FY2025 | Revenue | $132.50M – $133.50M | $138.30M | Above range |
| Q3 FY2025 | Revenue | $152.00M – $153.00M | $168.60M | Above range |
| Q2 FY2025 | Revenue | $126.50M – $127.50M | $136.80M | Above range |
| Q1 FY2025 | Revenue | $119.50M – $120.50M | $126.70M | Above range |
| Q4 FY2024 | Revenue | $115.90M – $116.90M | $118.10M | Above range |
| Q3 FY2024 | Revenue | $127.00M – $128.00M | $135.30M | Above range |
| Q2 FY2024 | Revenue | $108.50M – $109.50M | $113.60M | Above range |
| Q1 FY2024 | Revenue | $106.50M – $107.50M | $108.50M | Above range |
| Q4 FY2023 | Revenue | $109.60M – $110.60M | $111.00M | Above range |
| Q3 FY2023 | Revenue | $110.70M – $111.70M | $115.30M | Above range |
| Q2 FY2023 | Revenue | $99.50M – $100.50M | $102.20M | Above range |
| Q1 FY2023 | Revenue | $88.60M – $89.60M | $90.60M | Above range |
| Q4 FY2022 | Revenue | $89.00M – $90.00M | $93.70M | Above range |
| Q3 FY2022 | Revenue | $85.80M – $86.80M | $97.90M | Above range |
Guidance history
Every forecast Doximity put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | Adjusted EBITDA | FY2027 | $317.00M – $325.00M | – |
| Nov 5, 2026 | Adjusted EBITDA | Q3 FY2027 | $102.50M – $103.50M | – |
| Nov 5, 2026 | Revenue | FY2027 | $678.00M – $683.00M | – |
| Nov 5, 2026 | Revenue | Q3 FY2027 | $195.00M – $196.00M | – |
| Aug 6, 2026 | Adjusted EBITDA | FY2027 | $309.00M – $329.00M | Lowered |
| Aug 6, 2026 | Adjusted EBITDA | Q2 FY2027 | $80.50M – $81.50M | New |
| Aug 6, 2026 | Revenue | FY2027 | $671.00M – $681.00M | Raised |
| Aug 6, 2026 | Revenue | Q2 FY2027 | $170.00M – $171.00M | New |
| May 13, 2026 | Adjusted EBITDA | FY2027 | $323.00M – $335.00M | New |
| May 13, 2026 | Adjusted EBITDA | Q1 FY2027 | $68.50M – $69.50M | New |
| May 13, 2026 | Revenue | FY2027 | $664.00M – $676.00M | New |
| May 13, 2026 | Revenue | Q1 FY2027 | $151.00M – $152.00M | New |
| Feb 5, 2026 | Adjusted EBITDA | FY2026 | $355.50M – $356.50M | Narrowed |
| Feb 5, 2026 | Adjusted EBITDA | Q4 FY2026 | $63.50M – $64.50M | New |
| Feb 5, 2026 | Revenue | FY2026 | $642.50M – $643.50M | New |
| Feb 5, 2026 | Revenue | Q4 FY2026 | $143.00M – $144.00M | New |
| Nov 6, 2025 | Adjusted EBITDA | FY2026 | $351.00M – $357.00M | Raised |
| Nov 6, 2025 | Adjusted EBITDA | Q3 FY2026 | $103.00M – $104.00M | New |
| Nov 6, 2025 | Revenue | FY2026 | $640.00M – $646.00M | Raised |
| Nov 6, 2025 | Revenue | Q3 FY2026 | $180.00M – $181.00M | New |
| Aug 7, 2025 | Adjusted EBITDA | FY2026 | $341.00M – $349.00M | Raised |
| Aug 7, 2025 | Adjusted EBITDA | Q2 FY2026 | $87.00M – $88.00M | New |
| Aug 7, 2025 | Revenue | FY2026 | $628.00M – $636.00M | Raised |
| Aug 7, 2025 | Revenue | Q2 FY2026 | $157.00M – $158.00M | New |
| May 15, 2025 | Adjusted EBITDA | FY2026 | $333.00M – $345.00M | New |
| May 15, 2025 | Adjusted EBITDA | Q1 FY2026 | $71.00M – $72.00M | New |
| May 15, 2025 | Revenue | FY2026 | $619.00M – $631.00M | New |
| May 15, 2025 | Revenue | Q1 FY2026 | $139.00M – $140.00M | New |
| Feb 6, 2025 | Adjusted EBITDA | FY2025 | $306.60M – $307.60M | New |
| Feb 6, 2025 | Adjusted EBITDA | Q4 FY2025 | $62.50M – $63.50M | New |
| Feb 6, 2025 | Revenue | FY2025 | $564.60M – $565.60M | New |
| Feb 6, 2025 | Revenue | Q4 FY2025 | $132.50M – $133.50M | New |
| Nov 7, 2024 | Adjusted EBITDA | FY2025 | $274.00M – $279.00M | Raised |
| Nov 7, 2024 | Adjusted EBITDA | Q3 FY2025 | $83.00M – $84.00M | New |
| Nov 7, 2024 | Revenue | Q3 FY2025 | $152.00M – $153.00M | New |
| Nov 7, 2024 | Revenue | FY2025 | $535.00M – $540.00M | New |
| Aug 8, 2024 | Adjusted EBITDA | Q2 FY2025 | $62.50M – $63.50M | New |
| Aug 8, 2024 | Adjusted EBITDA | FY2025 | $248.50M – $257.50M | Raised |
| Aug 8, 2024 | Revenue | Q2 FY2025 | $126.50M – $127.50M | New |
| Aug 8, 2024 | Revenue | FY2025 | $514.00M – $523.00M | Raised |
| May 16, 2024 | Adjusted EBITDA | Q1 FY2025 | $55.00M – $56.00M | New |
| May 16, 2024 | Adjusted EBITDA | FY2025 | $238.00M – $250.00M | New |
| May 16, 2024 | Revenue | FY2025 | $506.00M – $518.00M | New |
| May 16, 2024 | Revenue | Q1 FY2025 | $119.50M – $120.50M | New |
| Feb 8, 2024 | Adjusted EBITDA | Q4 FY2024 | $50.50M – $51.50M | New |
| Feb 8, 2024 | Adjusted EBITDA | FY2024 | $224.50M – $225.50M | Raised |
| Feb 8, 2024 | Revenue | FY2024 | $473.30M – $474.30M | Lowered |
| Feb 8, 2024 | Revenue | Q4 FY2024 | $115.90M – $116.90M | New |
| Nov 9, 2023 | Adjusted EBITDA | Q3 FY2024 | $61.00M – $62.00M | New |
| Nov 9, 2023 | Adjusted EBITDA | FY2024 | $207.00M – $219.00M | Raised |
| Nov 9, 2023 | Revenue | FY2024 | $460.00M – $472.00M | Raised |
| Nov 9, 2023 | Revenue | Q3 FY2024 | $127.00M – $128.00M | New |
| Aug 8, 2023 | Adjusted EBITDA | Q2 FY2024 | $44.00M – $45.00M | New |
| Aug 8, 2023 | Adjusted EBITDA | FY2024 | $193.00M – $209.00M | Lowered |
| Aug 8, 2023 | Revenue | FY2024 | $452.00M – $468.00M | Lowered |
| Aug 8, 2023 | Revenue | Q2 FY2024 | $108.50M – $109.50M | New |
| May 16, 2023 | Adjusted EBITDA | FY2024 | $216.00M – $222.00M | New |
| May 16, 2023 | Adjusted EBITDA | Q1 FY2024 | $39.00M – $40.00M | New |
| May 16, 2023 | Revenue | FY2024 | $500.00M – $506.00M | New |
| May 16, 2023 | Revenue | Q1 FY2024 | $106.50M – $107.50M | New |
| Feb 9, 2023 | Adjusted EBITDA | FY2023 | $180.20M – $181.20M | Narrowed |
| Feb 9, 2023 | Adjusted EBITDA | Q4 FY2023 | $45.20M – $46.20M | New |
| Feb 9, 2023 | Adjusted EBITDA margin | FY2024 | 43% | New |
| Feb 9, 2023 | Revenue | FY2024 | $500.00M | New |
| Feb 9, 2023 | Revenue | Q4 FY2023 | $109.60M – $110.60M | New |
| Feb 9, 2023 | Revenue | FY2023 | $417.70M – $418.70M | Lowered |
| Nov 10, 2022 | Adjusted EBITDA | Q3 FY2023 | $47.70M – $48.70M | New |
| Nov 10, 2022 | Adjusted EBITDA | FY2023 | $178.00M – $186.00M | Reaffirmed |
| Nov 10, 2022 | Revenue | Q3 FY2023 | $110.70M – $111.70M | New |
| Nov 10, 2022 | Revenue | FY2023 | $424.00M – $432.00M | Reaffirmed |
| Aug 4, 2022 | Adjusted EBITDA | Q2 FY2023 | $40.00M – $41.00M | New |
| Aug 4, 2022 | Adjusted EBITDA | FY2023 | $178.00M – $186.00M | Lowered |
| Aug 4, 2022 | Revenue | Q2 FY2023 | $99.50M – $100.50M | New |
| Aug 4, 2022 | Revenue | FY2023 | $424.00M – $432.00M | Lowered |
| May 17, 2022 | Adjusted EBITDA | Q1 FY2023 | $28.60M – $29.60M | New |
| May 17, 2022 | Adjusted EBITDA | FY2023 | $192.00M – $196.00M | New |
| May 17, 2022 | Revenue | Q1 FY2023 | $88.60M – $89.60M | New |
| May 17, 2022 | Revenue | FY2023 | $454.00M – $458.00M | New |
| Feb 8, 2022 | Adjusted EBITDA | Q4 FY2022 | $34.00M – $35.00M | New |
| Feb 8, 2022 | Adjusted EBITDA | FY2022 | $144.90M – $145.90M | Raised |
| Feb 8, 2022 | Adjusted EBITDA margin | FY2023 | 40% | New |
| Feb 8, 2022 | Revenue | Q4 FY2022 | $89.00M – $90.00M | New |
| Feb 8, 2022 | Revenue | FY2022 | $338.90M – $339.90M | New |
| Feb 8, 2022 | Revenue growth | FY2023 | +33% | New |
| Feb 8, 2022 | Revenue | FY2023 | $450.00M | New |
| Nov 9, 2021 | Adjusted EBITDA | Q3 FY2022 | $32.00M – $33.00M | New |
| Nov 9, 2021 | Adjusted EBITDA | FY2022 | $127.60M – $129.60M | New |
| Nov 9, 2021 | Revenue | Q3 FY2022 | $85.80M – $86.80M | New |
| Nov 9, 2021 | Revenue | FY2022 | $326.10M – $328.10M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Doximity filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?